Jacob Korach

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy

D Elkharrat, J RAPHAEL, Jacob Korach et al. · Intensive Care Medicine · 1991 · 159 citations

Hyperbaric Oxygen, Pregnancy, Maternal Health +6

Uterine Leiomyosarcoma: Does the Primary Surgical Procedure Matter?

Tamar Perri, Jacob Korach, Siegal Sadetzki et al. · International Journal of Gynecological Cancer · 2009 · 149 citations

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial

Jean‐Sébastien Frenel, J.W. Kim, Nanda Aryal et al. · Annals of Oncology · 2022 · 140 citations

Post-hoc Analyses, Medicine, Subsequent Chemotherapy +8